Jay Kalin, Ph.D.
Affiliations: | 2012 | Medicinal Chemistry | University of Illinois at Chicago, Chicago, IL, United States |
Area:
medicinal chemistryGoogle:
"Jay Kalin"Mean distance: 8.37 | S | N | B | C | P |
Parents
Sign in to add mentor| Alan P. Kozikowski | grad student | 2012 | University of Illinois, Chicago | |
| (Elucidation of the Histone Deacetylase 6 Pharmacophore.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cheng F, Lienlaf M, Wang HW, et al. (2024) Expression of Concern: A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs. Journal of Immunology (Baltimore, Md. : 1950). 213: 1044 |
| Padalino G, Celatka CA, Rienhoff HY, et al. (2023) Chemical modulation of lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes. Wellcome Open Research. 8: 146 |
| Gibson F, Hanly A, Kuang K, et al. (2020) 660 Dual HDAC and LSD1 inhibition as a novel strategy to overcome BRAF inhibitor resistance Journal of Investigative Dermatology. 140 |
| Anastas JN, Zee BM, Kalin JH, et al. (2019) Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell |
| Kida M, Falanga V, Wu M, et al. (2019) 941 Epigenetic manipulation of epidermal cells leads to enhanced cellular migration without an increase in cell proliferation Journal of Investigative Dermatology. 139: S162 |
| Wu M, Hayward D, Kalin JH, et al. (2018) Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex. Elife. 7 |
| Kalin JH, Wu M, Gomez AV, et al. (2018) Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors. Nature Communications. 9: 53 |
| Anastas J, Filbin M, Kim M, et al. (2018) Gene-22. Re-Programing Chromatin With A Bifunctional Lsd1/Hdac Inhibitor Induces Therapeutic Differentiation In Dipg Neuro-Oncology. 20 |
| Wu M, Kalin J, Ryu B, et al. (2017) Abstract 5068: A novel dual action inhibitor of histone deacetylase and demethylase in melanoma Cancer Research. 77: 5068-5068 |
| Lu S, Zhang Y, Kalin JH, et al. (2015) Exploration of the labeling of [(11) C]tubastatin A at the hydroxamic acid site with [(11) C]carbon monoxide. Journal of Labelled Compounds & Radiopharmaceuticals |